Patent Assignment
Reel/Frame 012636/0729
Assignment of Assignor's Interest
Recorded: 2002-04-30
Pages: 4
Assignee
FLEMING & COMPANY
1733 GILSINN LANE, FENTON, MISSOURI, 63026
Covered Property
(1)
Treating Eczema with a Combination of Isotonic Saline Ocean and Nasal Mast Cell Stabilizers
Patent:
6,596,284 →
Application:
10/063,493 →
Related Assignments
(15)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the 2ND Assignor's Name. Document Previously Recorded on Reel 012636 Frame 0729 Asignor Hereby Confirms the Assignment of the Entire Interest.
Oct 15, 2002
From: FLEMING, THOMAS E.; FELLER, THEODORE H
To: FLEMING & COMPANY
Reel/Frame 013399/0802 →
Assignment of Assignor's Interest
Feb 2, 2012
From: FLEMING AND COMPANY, PHARMACEUTICALS
To: VALEANT INTERNATIONAL (BARBADOS) SRL
Reel/Frame 027641/0093 →
Security Agreement
Jul 30, 2012
From: VALEANT INTERNATIONAL BERMUDA (FORMERLY KNOWN AS VALEANT INTERNATIONAL (BARBADOS) SRL); VALEANT LABORATORIES INTERNATIONAL BERMUDA (FORMERLY KNOWN AS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL)
To: GOLDMAN SACHS LENDING PARTNERS LLC
Reel/Frame 028680/0866 →
Change in Name and Country of Incorporation
Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Assignment of Assignor's Interest
Mar 26, 2013
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
Reel/Frame 030087/0301 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Security Interest
Jul 19, 2017
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043046/0217 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest
Oct 24, 2019
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 051803/0911 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →